Bright Minds Biosciences to Host Symposium on Therapeutic Developments
Link Title
Link Short URL
Link Long URL
Description:
Bright Minds Biosciences a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced that Ian McDonald, Chief Executive Officer, Dr. Revati Shreeniwas, Chief Medical Officer, Professor John McCorvy, PhD, Senior Advisor, and other key speakers will host a symposium on the recent therapeutic developments within the Dravet Syndrome landscape.
Keywords (Tags):
Created by:
Bright Minds Biosciences
Created on:
Hits:
396
|